ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Pharming Group NV

Pharming Group NV (PHAR)

8.77
0.28
( 3.30% )
Updated: 11:41:11

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
EUR (€)EUR (€)EUR (€)EUR (€)USD ($)USD ($)USD ($)USD ($)
Total Assets 393.9M382.32M425.8M423M429.81M436.47M461.42M441.67M
Total Current Assets 256.98M252.05M277.5M266.06M278.57M291.74M316.34M296.55M
Cash and Equivalents 189.96M188.7M207.34M184.78M192.37M54.65M61.52M51.89M
Total Non-Current Assets 118.63M113.31M119.54M126.57M121.8M116.9M121.31M122.27M
Total Liabilities 194.23M182.07M221.16M223.65M229.43M226.53M242.24M235.72M
Total Current Liabilities 49.19M46.69M59.7M59M64.95M68.06M76.13M207.29M
Total Non-Current Liabilities 289.92M270.61M322.92M329.3M328.96M316.93M332.21M56.88M
Common Equity 7.47M7.48M7.51M7.52M7.54M7.65M7.67M7.68M
Retained Earnings -253.55M-242.53M-256.43M-266.49M-265.49M-262.78M-264.83M-277.39M
Year End December 30 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)USD ($)USD ($)USD ($)USD ($)
Total Assets 126.78M166.19M214.48M228.21M418.45M397.32M425.8M462.85M
Total Current Assets 62.19M88.25M115.44M106.5M263.21M249.44M277.5M316.34M
Cash and Equivalents 31.89M58.66M80.31M66.3M205.16M191.92M207.34M61.74M
Total Non-Current Assets 27.47M16.11M61.75M104.68M183.44M192.92M204.64M218.78M
Total Liabilities 99.32M150.08M152.73M123.53M235.02M204.4M221.16M244.07M
Total Current Liabilities 51.38M60.74M82.6M101.89M76.85M46.77M59.7M77.97M
Total Non-Current Liabilities 88.93M148.89M107.56M26.01M316.13M315.09M322.92M302.7M
Total Equity 27.47M16.11M61.75M104.68M183.44M192.92M204.64M218.78M
Common Equity 4.56M5.79M6.22M6.31M7.31M7.43M7.51M7.67M
Retained Earnings -279.03M-352.56M-333.64M-297.62M-295.62M-273.17M-256.43M-265.26M